Ketamine has promise as a potential treatment for bipolar depression, particularly for people whose condition hasn’t ...

There are many doctors who can assist in bipolar disorder treatment, but the main ones include a psychiatrist and ...

Baszucki Group invests in two pioneering youth bipolar treatment initiatives exploring ketogenic metabolic therapy in ...

Working in partnership with clinicians, researchers, and people living with bipolar disorder, the BD² Integrated Network was established to expand knowledge of bipolar disorder while accelerating the ...

For 4.8 million Americans with bipolar I disorder, consistent treatment prevents severe mood swings; experts share six ...

An analysis of the FINEXT-BD data found that individuals with bipolar disorder have a 3.1% risk of cardiovascular events, ...

People with bipolar disorder who followed a ketogenic diet for at least six weeks found that their symptoms improved, a new ...

Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) announced four new national institutions to receive $2.3 million each to join the BD² Integrated Network, a collaborative research and ...

The purpose of this study is to create a database of information that allows researchers to explore how genetics and other biomarkers are impacted by bipolar disorder and its treatment.

Biohaven’s pipeline drug BHV-7000 has failed to meet the primary endpoint in a pivotal Phase II/III bipolar trial.